Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jfo.2019.08.029 | DOI Listing |
Rom J Ophthalmol
July 2024
Dept of Ophthalmology, Command Hospital (Air Force), Bangalore, India.
This case report aimed to describe the unusual clinical presentation and histopathological features of post-injection endophthalmitis. A 56-year-old male phakic patient with diabetic retinopathy received an intravitreal injection (Bevacizumab as per the patient) for neovascular glaucoma elsewhere and presented to our center one day after the dose with hypopyon. The eye was relatively white without pain or lid oedema.
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
June 2023
Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (deemed to be) University, 8-Kalinga Nagar, Bhubaneswar 751003, Odisha.
Post-operative endophthalmitis is a vision threatening complication following intraocular surgery requiring prompt treatment. Clinical picture mimicking infectious endophthalmitis can rarely be produced following intravitreal triamcinolone acetonide injection. A 65-year-old male with previous history of pars plana vitrectomy and lens removal was diagnosed with post-operative cystoid macular edema in his right eye.
View Article and Find Full Text PDFCan J Ophthalmol
December 2020
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ont.; Kensington Vision and Research Centre, Toronto, Ont.. Electronic address:
Objective: To review the literature on noninfectious endophthalmitis (NIE) following intravitreal triamcinolone acetonide (IVTA).
Design: A literature review and case report.
Participants: Individuals who developed NIE after IVTA injection.
J Fr Ophtalmol
May 2020
Service d'ophtalmologie, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13005 Marseille, France.
Bull Soc Belge Ophtalmol
September 2007
Service d'Ophtalmologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles.
Intravitreal injections of triamcinolone acetonide are today widely performed as a therapeutic tool for a large variety of ocular diseases. The risk of toxicity of the product and its vehicle is quite real and is still at the center of investigations. Complications related to the substance and the technique of injections are already well-known (intraocular pressure rise, cataract, endophthalmitis, pseudo-endophthalmitis, vitreous haemorrhage and retinal detachment).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!